Aurora Earnings Also Boasts Industry-Leading Cannabis Gross Margin
ACB Stock Plummets More Than 12% in After-Hours Trading
Aurora Cannabis (TSX: ACB) (NYSE: ACB) announced its Q1 2020 earnings today after the closing bell. Aurora reported net revenue for the quarter of $75.24 million, a decrease of 24% compared to the $98.94 million reported in the previous quarter. The consensus amongst analysts projected Aurora would report net revenue of $90.6 million.
Cannabis net revenue dropped 25% quarter over quarter from $94.64 million in Q4 2019 to $70.78 million in Q1 2020. Medical cannabis net revenue increased 3% Q over Q from $29.65 million to $30.45 million. Gross margin on cannabis net revenue came in at 58% for the quarter.
Aurora posted an industry-leading gross profit for the first quarter of $53.7 million. The company attributes this positive growth to a substantial reduction in its cash cost of production.
Adjusted EBITDA loss for the first quarter was $39.7 million compared to the $26.6 million loss in Q4 2019. This excluded the impact of the $14.9 million out-of-period adjustments recognized in the prior quarter. Aurora cited near-term challenges that held the company back from achieving positive adjusted EBITDA.
Aurora delivered on its commitment to reduce its cost per gram to below $1 by decreasing its cost per gram by 25% to $0.85. The company achieved an average net selling price of $5.68 per gram of cannabis in Q1, an increase of $0.36 over the previous quarter.
During the quarter, Aurora produced 41,436 kgs of cannabis, a 42.7% increase over the 29,034 kgs produced last quarter. The large increase in production was mostly due to the company’s continued production scale-up at its Aurora Sky facility.
Source: Shutterstock
The company put a halt on construction at its Aurora Nordic 2 facility in Denmark. This move is expected to save the company around $80 million over the next year.
Aurora also disclosed it has reached an agreement with investors holding roughly $155 million of the company’s March 2020 convertible debentures. The deal will allow these investors to convert early at a reduced price.
Aurora is optimistic about the future due to cannabis 2.0 products coming online in Canada at the end of this year. As with Canopy Growth (TSX: WEED) (NYSE: ACB) which also reported earnings today, Aurora has made significant investments leading up to legalization 2.0 and will now have the opportunity to enjoy the fruits of its labour.
Aurora says it’s “extremely well-positioned and has prioritized its resources to prepare for a successful initial launch and supported an ongoing replenishment strategy to ensure consumers across Canada will have access to a diverse portfolio of high-quality derivative products they want to buy.”
The company anticipates it will begin shipping its new cannabis 2.0 products to provincial regulators in late December of this year.
Shares of Aurora’s TSX listed stock closed trading today at $4.38 per share, down 6.61% on the day. Aurora released earnings after the market closed today causing its NYSE listed stock to plummet in after-hours trading. Currently, ACB on the NYSE is trading at $2.88 per share, down 12.46% in the after-hours session.
Source: Barchart.com
Learn more about Aurora Cannabis: Website | IR Website | Investor Deck | ACB Chart
Also Read: Canopy Growth Posts Astonishing $374.6 Million 2nd Quarter Loss, Pot Stocks Plunge
<<< Get Your Copy of The Ultimate Cannabis Investing Guide >>>
The Most Anticipated Cannabis IPO of 2019 Has Finally Arrived
Move Over Curaleaf, There’s a New MSO in Town and it’s Set to Hit The Street Soon
Get the full details here so you don’t miss out on the next potential 10 bagger.
Join the Discussion in the TCI Investor Group
Read More:
Featured ArticlesCannabis Stock NewsCannabis Industry ArticlesTechnical Analysis ArticlesWatch Cannabis Stock Videos
